{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:25:44Z","timestamp":1792211144508,"version":"4.4.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.heliyon.2020.e04663","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T09:29:06Z","timestamp":1597829346000},"page":"e04663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Recent advances in topical carriers of anti-fungal agents"],"prefix":"10.1016","volume":"6","author":[{"given":"Abhinava","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganti S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudam Chandra","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clindermatol.2009.12.005","article-title":"Epidemiology of superficial fungal infections","volume":"28","author":"Ameen","year":"2010","journal-title":"Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses","volume":"51","author":"Havlickova","year":"2008","journal-title":"Worldwide Mycoses"},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.det.2007.01.002","article-title":"Advances in topical and systemic anti-fungal","volume":"25","author":"Zhang","year":"2007","journal-title":"Clin. Dermatol."},{"issue":"No. 2","key":"10.1016\/j.heliyon.2020.e04663_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clindermatol.2009.12.005","article-title":"Epidemiology of superficial fungal infections","volume":"28","author":"Ameen","year":"2010","journal-title":"Clin. Dermatol."},{"issue":"Suppl. 4","key":"10.1016\/j.heliyon.2020.e04663_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological Trends in Skin Mycoses Worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.heliyon.2020.e04663_bib6","first-page":"40","article-title":"Mycotic infections. Effective management of conditions involving the skin, hair, and nails","volume":"55","author":"Goldstein","year":"2000","journal-title":"Geriatrics"},{"key":"10.1016\/j.heliyon.2020.e04663_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3810\/pgm.2001.01.830","article-title":"Superficial fungal infection of the skin. Where and how it appears help determine therapy","volume":"109","author":"Zuber","year":"2001","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.heliyon.2020.e04663_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mjd.2002.120603","article-title":"Tinea corporis gladiatorum","volume":"47","author":"Adams","year":"2002","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib9","first-page":"59","article-title":"Subcutaneous mycoses","volume":"17","author":"Queiroz-Telles","year":"2003","journal-title":"Infect. Dis. Clin."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-5173(94)00214-P","article-title":"Transdermal delivery of tacrine. I. Identification of a suitable delivery vehicle","volume":"114","author":"Sathyan","year":"1995","journal-title":"Int J Pharm"},{"key":"10.1016\/j.heliyon.2020.e04663_bib11","first-page":"557","article-title":"Preparation and evaluation of fluconazole topical microemulsion","volume":"3","author":"Magdum","year":"2009","journal-title":"J.\u00a0Pharm. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib12","first-page":"342","article-title":"Comparative evaluation of efficacy and safety of topical fluconazole and clotrimazole in the treatment of Tinea corporis","volume":"22","author":"Banerjee","year":"2012","journal-title":"J.\u00a0Pak. Assoc. Dermatol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib13","first-page":"56","article-title":"New formulation strategies in topical antifungal therapy","volume":"3","author":"Gungor","year":"2013","journal-title":"J.\u00a0Chem. Dermatol. Sci. Appl."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib14","first-page":"1","article-title":"Surfactant-based transdermal system for fluconazole skin delivery","volume":"5","author":"Silva","year":"2014","journal-title":"J.\u00a0Nanomed. Nanotechnol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","article-title":"Transdermal drug delivery: overcoming the skin\u2019s barrier function","volume":"3","author":"Naik","year":"2000","journal-title":"Pharmaceut. Sci. Technol. Today"},{"key":"10.1016\/j.heliyon.2020.e04663_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/313748","article-title":"Introduction to antifungal drugs","volume":"30","author":"Dismukes","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2020.e04663_bib17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2174\/138955707781662672","article-title":"Recent advances in antifungal agents","volume":"7","author":"Lorand","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0163-7258(95)00011-5","article-title":"P450 inhibitors of use in medical treatment: focus on mechanisms of action","volume":"67","author":"Bossche","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2020.e04663_bib19","first-page":"353","article-title":"Fluconazole topical microemulsion: preparation and evaluation","volume":"2","author":"Shah","year":"2009","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib20","first-page":"104","article-title":"Future of antimycotic therapy","volume":"3","author":"Ghannoum","year":"1997","journal-title":"Dermatol. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib21","first-page":"2706","article-title":"Conservation between human and fungal squalene synthetases: similarities in structure, function, and regulation","volume":"13","author":"Robinson","year":"1993","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib22","first-page":"130","article-title":"Antifungal agents: mode of action in yeast cells","volume":"19","author":"Carrillo-Munoz","year":"2006","journal-title":"Rev. Esp. Quimioter."},{"key":"10.1016\/j.heliyon.2020.e04663_bib23","doi-asserted-by":"crossref","DOI":"10.1139\/cjm-2018-0082","article-title":"Antifungal activity of essential oils against azole-resistant and azole-susceptible Candida glabrata strains vaginal isolates","author":"Massa","year":"2018","journal-title":"Can. J. Microbiol."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04663_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ajme.2015.10.001","article-title":"Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis","volume":"52","author":"ElFeky","year":"2016","journal-title":"Alexandria J Medicine"},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7241\/ourd.20152.58","article-title":"Antifungal drugs and resistance: current concepts","volume":"6","author":"Nigam","year":"2015","journal-title":"Our Dermatol. Online"},{"issue":"19","key":"10.1016\/j.heliyon.2020.e04663_bib26","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","article-title":"The biology and chemistry of antifungal agents: a review","volume":"20","author":"Kathiravan","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e04663_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3201\/eid0809.020063","article-title":"Biofilms: microbial life on surfaces","volume":"8","author":"Donlan","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e04663_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.mi.41.100187.002251","article-title":"Bacterial biofilms in nature and disease","volume":"41","author":"Costerton","year":"1987","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/322972","article-title":"Biofilm formation: a clinically relevant microbiological process","volume":"33","author":"Donlan","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e04663_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1567-1364.2006.00117.x","article-title":"Candida biofilms on implanted biomaterials: a clinically significant problem","volume":"6","author":"Ramage","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.heliyon.2020.e04663_bib31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.heliyon.2020.e04663_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10408410903241436","article-title":"Our current understanding of fungal biofilms","volume":"35","author":"Ramage","year":"2009","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002585","article-title":"Fungal biofilms","volume":"8","author":"Fanning","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2020.e04663_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s100960050001","article-title":"Intravascular catheter-associated infections","volume":"19","author":"Crump","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e04663_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CMR.17.2.255-267.2004","article-title":"Candida infections of medical devices","volume":"17","author":"Kojic","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.heliyon.2020.e04663_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1462-5822.2009.01409.x","article-title":"In vivo biofilm composition of Aspergillus fumigatus","volume":"12","author":"Loussert","year":"2010","journal-title":"Cell Microbiol."},{"issue":"Suppl. 1","key":"10.1016\/j.heliyon.2020.e04663_bib37","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1080\/13693780802238834","article-title":"The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?","volume":"47","author":"Mowat","year":"2009","journal-title":"Med. Mycol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fmicb.2013.00013","article-title":"Investigation of Aspergillus fumigatus biofilm formation by various \u2018\u2018omics\u2019\u2019 approaches","volume":"4","author":"Muszkieta","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/08927014.2012.703659","article-title":"Adhesion of histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface","volume":"28","author":"Pitangui","year":"2012","journal-title":"Biofouling"},{"key":"10.1016\/j.heliyon.2020.e04663_bib40","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1128\/AEM.02506-06","article-title":"Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light","volume":"73","author":"Martinez","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11046-008-9180-6","article-title":"Biofilm formation by Cryptococcus neoformans under distinct environmental conditions","volume":"167","author":"Ravi","year":"2009","journal-title":"Mycopathologia"},{"key":"10.1016\/j.heliyon.2020.e04663_bib42","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1371\/journal.ppat.0020063","article-title":"Critical role of bcr1- dependent adhesions in C. albicans biofilm formation in vitro and in vivo","volume":"2","author":"Nobile","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2020.e04663_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","article-title":"A\u00a0recently evolved transcriptional network controls biofilm development in Candida albicans","volume":"148","author":"Nobile","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2020.e04663_bib44","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of Amphotericin b lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2020.e04663_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2016.00011","article-title":"Emerging threats in antifungal-resistant fungal pathogens","volume":"3","author":"Sanglard","year":"2016","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2020.e04663_bib46","series-title":"Transdermal and Topical Drug Delivery: from Theory to Clinical Practice","author":"Williams","year":"2003"},{"issue":"12","key":"10.1016\/j.heliyon.2020.e04663_bib47","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1023\/A:1016060403438","article-title":"Current status and future prospects of transdermal drug delivery","volume":"13","author":"Guy","year":"1996","journal-title":"Pharmaceut. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fernandez-Campos","year":"2013","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Souto","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2020.e04663_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Souto","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.heliyon.2020.e04663_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02652040500162436","article-title":"SLN and NLC for topical delivery of ketoconazole","volume":"22","author":"Souto","year":"2005","journal-title":"J.\u00a0Microencapsul."},{"key":"10.1016\/j.heliyon.2020.e04663_bib52","first-page":"410","article-title":"The system SLN- Dextrin hydrogel: an application for the topical delivery of ketoconazole","volume":"3","author":"Paolicellia","year":"2011","journal-title":"J.\u00a0Chem. Pharmaceut. Res."},{"issue":"No. 8","key":"10.1016\/j.heliyon.2020.e04663_bib53","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1211\/jpp.59.8.0002","article-title":"Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro charac- terization, ex-vivo and in-vivo studies","volume":"59","author":"Sanna","year":"2007","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"No. 5","key":"10.1016\/j.heliyon.2020.e04663_bib54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1211\/jpp.61.05.0003","article-title":"Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate","volume":"61","author":"Passerini","year":"2009","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"No. 1","key":"10.1016\/j.heliyon.2020.e04663_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12249-009-9199-0","article-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","volume":"10","author":"Bhalekar","year":"2009","journal-title":"AAPS Pharmaceutical Science Technology"},{"key":"10.1016\/j.heliyon.2020.e04663_bib56","first-page":"1","article-title":"Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery","volume":"21","author":"Cassano","year":"2015","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib57","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jac\/dkl312","article-title":"Cationic lipids and surfactants as antifungal agents: mode of action","volume":"58","author":"Vieira","year":"2006","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib58","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.drudis.2016.01.004","article-title":"Cubosomes: remarkable drug delivery potential","volume":"21","author":"Karami","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib59","first-page":"431","article-title":"The use of SLN\u00ae and NLC\u00ae as topical particulate carriers for imidazole antifungal agents","volume":"61","author":"Souto","year":"2006","journal-title":"Die Pharmazie-An Int J Pharmaceutical Sci"},{"issue":"43","key":"10.1016\/j.heliyon.2020.e04663_bib60","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.2174\/1381612823666171115112745","article-title":"SLN-and NLC-encapsulating antifungal agents: skin drug delivery and their unexplored potential for treating onychomycosis","volume":"23","author":"Gratieri","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","article-title":"Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis vesicolor: formulation and clinical study","volume":"25","author":"El-Housiny","year":"2018","journal-title":"Drug Deliv."},{"issue":"12","key":"10.1016\/j.heliyon.2020.e04663_bib62","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/BF00577761","article-title":"Liposomal tretinoin for uncomplicated acne vulgaris","volume":"72","author":"Schafer-Korting","year":"1994","journal-title":"Clin. Invest."},{"issue":"5-6","key":"10.1016\/j.heliyon.2020.e04663_bib63","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0731-7085(01)00502-7","article-title":"Liposomes with tretinoin: a physical and chemical evaluation","volume":"26","author":"Brisaert","year":"2001","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2020.e04663_bib64","first-page":"42","article-title":"Formulation and evaluation of carbopol gel containing Liposomes of ketoconazole","volume":"1","author":"Patel","year":"2009","journal-title":"Int J Drug Deliv Techno"},{"issue":"No. 5","key":"10.1016\/j.heliyon.2020.e04663_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/10611869908996843","article-title":"Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations","volume":"6","author":"Schaller","year":"1999","journal-title":"J.\u00a0Drug Target."},{"issue":"1-2","key":"10.1016\/j.heliyon.2020.e04663_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00183-2","article-title":"Particle size of liposomes influences dermal delivery of substances into skin","volume":"258","author":"Verma","year":"2003","journal-title":"International J Pharmaceutics"},{"key":"10.1016\/j.heliyon.2020.e04663_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1874126600701010036","article-title":"Innovative strategies for enhancing topical and transdermal drug delivery","volume":"1","author":"Morrow","year":"2007","journal-title":"Open Drug Deliv. J."},{"key":"10.1016\/j.heliyon.2020.e04663_bib68","first-page":"45","article-title":"Liposomes and niosomes interactions with human skin","volume":"106","author":"Junginger","year":"1991","journal-title":"Cosmet. Toilet."},{"issue":"No. 5","key":"10.1016\/j.heliyon.2020.e04663_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000086666","article-title":"Liposomes and niosomes as drug delivery systems","volume":"18","author":"Choi","year":"2005","journal-title":"Skin Pharmacol. Physiol."},{"issue":"No. 6","key":"10.1016\/j.heliyon.2020.e04663_bib70","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/10731199.2011.611476","article-title":"Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery","volume":"36","author":"Gupta","year":"2011","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechno."},{"issue":"No. 5","key":"10.1016\/j.heliyon.2020.e04663_bib71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/03639040802498864","article-title":"Development of naftifine hydrochloride alcohol-free niosomes gel","volume":"35","author":"Barakat","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib72","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/03639040802498864","article-title":"Development of naftifine hydrochloride alcohol-free niosome gel","volume":"35","author":"Barakat","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1145\/1053283.1053287","article-title":"Establishing pairwise keys in distributed sensor networks","volume":"8","author":"Liu","year":"2005","journal-title":"ACM Trans. Inf. Syst. Secur."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/folmed-2017-0051","article-title":"Microemulgel of voriconazole: an unfathomable protection to counter fungal contagiousness","volume":"59","author":"Ashara","year":"2017","journal-title":"Folia Med."},{"issue":"No. 1","key":"10.1016\/j.heliyon.2020.e04663_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2010.11.003","article-title":"Potentials of new nanocarriers for dermal and transdermal drug delivery","volume":"77","author":"Neubert","year":"2011","journal-title":"European J Pharmacy Biopharmacy"},{"key":"10.1016\/j.heliyon.2020.e04663_bib76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","article-title":"Microemulsions as transdermal drug delivery vehicles","volume":"123\u2013126","author":"Kogan","year":"2006","journal-title":"Adv. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04663_bib77","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1208\/s12249-009-9286-2","article-title":"Effect of formulation components on the in-vitro permeation of microemulsion drug delivery system of fluconazole","volume":"10","author":"Patel","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2020.e04663_bib78","first-page":"S77-98","article-title":"Influence of microemulsions on cutaneous drug delivery","volume":"54","author":"Kreilgaard","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2020.e04663_bib79","first-page":"E35","article-title":"The development of cutina lipogels and gel microemulsion for topical administration of fluconazole","volume":"3","author":"El Laithy","year":"2002","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.heliyon.2020.e04663_bib80","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/03639045.2017.1318899","article-title":"Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation","volume":"43","author":"Radwan","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib81","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/10837450.2016.1230629","article-title":"Effect of chitosan coating on microemulsion for effective dermal clotrimazole delivery","volume":"22","author":"Kumari","year":"2017","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib82","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1208\/s12249-010-9457-1","article-title":"Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms","volume":"11","author":"Salerno","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2020.e04663_bib83","first-page":"65","article-title":"Investigating the effect of vehicle on in- vitro skin permeation of ketoconazole applied in O\/W micro emulsions","volume":"52","author":"Patel","year":"2010","journal-title":"Acta Pharm Sci"},{"issue":"No. 3","key":"10.1016\/j.heliyon.2020.e04663_bib84","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/10837451003610845","article-title":"Investigating effect of microemulsion com- ponents: In vitro permeation of ketoconazole","volume":"16","author":"Patel","year":"2011","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4333\/KPS.2010.40.5.305","article-title":"Microemulsion- based hydrogel formulation of itraconazole for topical delivery","volume":"40","author":"Lee","year":"2010","journal-title":"J\u00a0Pharm Investig"},{"key":"10.1016\/j.heliyon.2020.e04663_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2231-4040.79802","article-title":"Investigation of microemulsion system for transdermal delivery of itraconazole","volume":"2","author":"Chudasama","year":"2011","journal-title":"\"J. Adv. Pharm. Technol. Research\"\" (JAPTR)\""},{"key":"10.1016\/j.heliyon.2020.e04663_bib87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/03639045.2011.590731","article-title":"Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation","volume":"38","author":"El- Hadidy","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.heliyon.2020.e04663_bib88","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2014.02.012","article-title":"Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle- skin interaction","volume":"465","author":"Ge","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.heliyon.2020.e04663_bib89","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1208\/s12249-011-9653-7","article-title":"Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery","volume":"12","author":"Hashem","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib90","first-page":"580","article-title":"Design and evaluation of micro emulsion based drug delivery system","volume":"1","author":"Jadhav","year":"2010","journal-title":"Asian J Exp Biol Sci"},{"key":"10.1016\/j.heliyon.2020.e04663_bib91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2018.11.002","article-title":"Clares-Naveros B. Biopharmaceutical profile of a clotrimazole nanoemulsion: evaluation on skin and mucosae as anticandidal agent","volume":"554","author":"Soriano-Ruiz","year":"2019","journal-title":"Int J Pharmaceutics"},{"issue":"7","key":"10.1016\/j.heliyon.2020.e04663_bib92","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.nano.2017.06.021","article-title":"Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis","volume":"13","author":"Sosa","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04663_bib93","first-page":"222","article-title":"A\u00a0review on various pharmaceutical applications","volume":"6","author":"Thakur","year":"2012","journal-title":"Global J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib94","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles for controlled drug delivery-a review of the state of the art","volume":"50","author":"Muller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2005.10.002","article-title":"Effect of lipid containing, positively charged nanoemulsions on skin hydration, elasticity and erythema--an in vivo study","volume":"307","author":"Yilmaz","year":"2006","journal-title":"Int J Pharm"},{"issue":"No. 1","key":"10.1016\/j.heliyon.2020.e04663_bib96","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fernandez-Campos","year":"2013","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04663_bib97","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10837450903055502","article-title":"Criterion for Excipients Screening in the development of nanoemulsion formulation of three anti-inflammatory drugs","volume":"15","author":"Shakeel","year":"2010","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00578496","article-title":"Influence of alkaline pH on the direct lethal action of miconazole against Candida albicans","volume":"120","author":"Beggs","year":"1992","journal-title":"Mycopathologia"},{"key":"10.1016\/j.heliyon.2020.e04663_bib99","first-page":"206","article-title":"Microsponge drug delivery system","volume":"1","author":"Shafi","year":"2013","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2020.e04663_bib100","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4155\/tde.14.43","article-title":"Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy","volume":"5","author":"Bothiraja","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.heliyon.2020.e04663_bib101","series-title":"The Microsponge","first-page":"49","author":"Khopade","year":"1996"},{"key":"10.1016\/j.heliyon.2020.e04663_bib102","first-page":"56","article-title":"Patient counseling and derm therapy","volume":"19","author":"Fincham","year":"1994","journal-title":"U.S. Pharm."},{"key":"10.1016\/j.heliyon.2020.e04663_bib103","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.biomaterials.2009.11.070","article-title":"The influence of structural design of PLGA\/collagen hybrid scaffolds in cartilage tissue engineering","volume":"31","author":"Dai","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2020.e04663_bib104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"47","author":"Kataoka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"No. 1","key":"10.1016\/j.heliyon.2020.e04663_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2006","journal-title":"Pharmaceut. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib106","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/02652040500435295","article-title":"Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization","volume":"23","author":"Souto","year":"2006","journal-title":"J.\u00a0Microencapsul."},{"issue":"No. 2","key":"10.1016\/j.heliyon.2020.e04663_bib107","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2011.03.003","article-title":"Novel micelle formulations to increase cutaneous bioavailability of azole antifungals","volume":"153","author":"Bachhav","year":"2011","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.heliyon.2020.e04663_bib108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2011.03.003","article-title":"Novel micelle formulations to increase cutaneous bioavailability of azoles antifungal","volume":"153","author":"Bachhav","year":"2011","journal-title":"J.\u00a0Contr. Release"},{"issue":"8","key":"10.1016\/j.heliyon.2020.e04663_bib109","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","article-title":"Micro fabricated microneedles: a novel approach to transdermal drug delivery","volume":"87","author":"Sebastien","year":"1998","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.heliyon.2020.e04663_bib110","unstructured":"Trautman, J., Wong, P.S., Daddona, P.E., Kim, H.L. and Zuck, M.G., \u201cDevice for enhancing transdermal agent flux,\u201dUS Patent No., U. S. Jpn. Outlook 6,322,808 B1, 2001."},{"key":"10.1016\/j.heliyon.2020.e04663_bib111","unstructured":"Gerstel, M.S. and Place, V.A. \u201cDrug Delivery Device,\u201d US Patent No., US3, 964, 482, 1976."},{"key":"10.1016\/j.heliyon.2020.e04663_bib112","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","article-title":"Effect of microneedle design on pain in human volunteers","volume":"24","author":"Gill","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.heliyon.2020.e04663_bib113","doi-asserted-by":"crossref","DOI":"10.1116\/1.4913378","article-title":"Polyglycolic acid microneedle modified with inkjet-deposited antifungal coatings","volume":"10","author":"Boehm","year":"2015","journal-title":"Biointerphases"},{"key":"10.1016\/j.heliyon.2020.e04663_bib114","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mattod.2014.04.027","article-title":"Inkjet printing for pharmaceutical applications","volume":"17","author":"Boehm","year":"2014","journal-title":"Mater. Today"},{"key":"10.1016\/j.heliyon.2020.e04663_bib115","series-title":"New Medical Technique Punches Holes in Cells, Could Treat Tumors","author":"Yang","year":"2007"},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib116","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2217\/fmb-2017-0245","article-title":"Pulsed electric field-assisted sensitization of multidrug-resistant Candida albicans to antifungal drugs","volume":"13","author":"Novickij","year":"2018","journal-title":"Future Microbiol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib117","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0378-6323.16613","article-title":"Iontophoresis in dermatology","volume":"71","author":"Rai","year":"2005","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/mi.4.6.1","article-title":"Transdermal drug delivery: past, present","author":"Scheindlin","year":"2004","journal-title":"Future \" Molecular Interventions"},{"issue":"11","key":"10.1016\/j.heliyon.2020.e04663_bib119","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/ICO.0000000000001696","article-title":"Impact of iontophoresis and PACK-CXL corneal concentrations of antifungals in an in vivo model","volume":"37","author":"Kalkanci","year":"2018","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04663_bib120","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1208\/s12249-018-0977-4","article-title":"Influence of a combination of chemical enhancers and iontophoresis on in vitro transungual permeation of nystatin","volume":"19","author":"Monti","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2020.e04663_bib121","first-page":"67","article-title":"Nanogels as novel and versatile pharmaceuticals","volume":"4","author":"Dorwal","year":"2012","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2020.e04663_bib122","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1002\/anie.200900441","article-title":"Nanogels as pharmaceutical carriers: finite networks of infinite capabilities","volume":"48","author":"Kabanov","year":"2009","journal-title":"Angew Chem. Int Ed Engl"},{"key":"10.1016\/j.heliyon.2020.e04663_bib123","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1016\/j.biomaterials.2009.06.011","article-title":"Nanostructured hybrid hydrogel prepared by a combination of atom transfer radical polymerization and free radical polymerization","volume":"30","author":"Bencherif","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2020.e04663_bib124","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/ma3021420","article-title":"Self-assembled hydrogel nanoparticles for drug delivery applications","volume":"3","author":"Gon\u00e7alves","year":"2010","journal-title":"Materials"},{"key":"10.1016\/j.heliyon.2020.e04663_bib125","first-page":"95","article-title":"An overview of nanogel drug delivery system","volume":"3","author":"Sultana","year":"2013","journal-title":"J.\u00a0Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2020.e04663_bib126","first-page":"271","article-title":"Nanogel based artificial chaperone technology: an overview","author":"Singh","year":"2013","journal-title":"Am. J. Adv. Drug Deliv."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib127","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.biomaterials.2011.11.011","article-title":"Skin permeating Nanogel for the cutaneous co-delivery of two anti-inflammatory drugs","volume":"33","author":"Shah","year":"2012","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.heliyon.2020.e04663_bib128","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.carres.2010.05.029","article-title":"Synthesis, characterization, and antifungal activity of novel quaternary Chitosan derivatives","volume":"345","author":"Li","year":"2010","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.heliyon.2020.e04663_bib129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/mmy\/myw053","article-title":"Chitosan silver nanocomposite (CAgNC) as an antifungal agent against Candida albicans","volume":"55","author":"Kulatunga","year":"2017","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04663_bib130","first-page":"23","article-title":"Comparative study of the anti-fungal activity of zinc oxide and titanium dioxide nano and bulk particles with anti- fungal against fungi isolated from infected skin and dandruff flakes","volume":"3","author":"George","year":"2014","journal-title":"Res Rev J Microbiol Biotechnol"},{"key":"10.1016\/j.heliyon.2020.e04663_bib131","article-title":"Biosynthesis of zinc oxide nanoparticles by petals extract of Rosa indica L., its formulation as nail paint and evaluation of antifungal activity against fungi causing onychomycosis","author":"Tiwari","year":"2016","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib132","article-title":"Antimicrobial studies using sulphur nano particles on dandruff causing Malassezia yeasts","volume":"II","author":"Baskar","year":"2015"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib133","first-page":"43","article-title":"Fabrication of ketoconazole nanoparticles and their activity against Malassezia furfur","volume":"7","author":"Paralikar","year":"2015","journal-title":"Nusant Biosci"},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04663_bib134","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/ntrev-2015-0010","article-title":"Copper oxide nanoparticles: an anti-dermatophytic agent for Trichophyton spp","volume":"4","author":"Kumar","year":"2015","journal-title":"Nanotechnol. Rev."},{"issue":"6","key":"10.1016\/j.heliyon.2020.e04663_bib135","first-page":"1246","article-title":"Enhanced efficacy of ketoconazole coated silver nanoparticles against the fungus Malassezia furfur a dandruff causing agent","volume":"4","author":"Mathew","year":"2015","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2020.e04663_bib136","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12951-015-0147-8","article-title":"Effect of silver nanoparticles on Candida albicans biofilms: an ultra structural study","volume":"13","author":"Lara","year":"2015","journal-title":"J.\u00a0Nanobiotechnol."},{"key":"10.1016\/j.heliyon.2020.e04663_bib139","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/myc.12445","article-title":"Acidophilic actinobacteria synthesized silver nanoparticles showed remarkable activity against fungi-causing superficial mycoses in humans","volume":"59","author":"Anasane","year":"2016","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04663_bib141","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7439\/ijasr.v2i1.2965","article-title":"Synthesis of Evolvulus alsinoides derived gold nanoparticles for medical applications","volume":"2","author":"Anbarasu","year":"2016","journal-title":"Int. J. Adv. Sci. Res."},{"issue":"7","key":"10.1016\/j.heliyon.2020.e04663_bib142","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1211\/jpp.62.07.0002","article-title":"Chitosan-coated antifungal formulations for nebulisation","volume":"62","author":"Albasarah","year":"2010","journal-title":"J.\u00a0Pharm. Pharmacol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020315073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020315073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T21:02:53Z","timestamp":1754600573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020315073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":139,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2405844020315073"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04663","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in topical carriers of anti-fungal agents","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e04663"}}